Pablo Corral: Key Take‑Home Messages on Familial Hypercholesterolemia
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Zahid Ahmad et al. published in Journal of Clinical Lipidology, adding:
“Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
- FH is common (approx.1:311) and systematically underdiagnosed therefore the real problem is not rarity, it is detection
- Driven by lifelong LDL-C exposure, not a single value therefore risk equals LDL-C multiplied by time
- Genetics help, but phenotype rules therefore treat based on LDL-C burden, not just mutations
Diagnosis
- LDL-C ≥190 mg/dL (adults) indicates FH, but confirm clinically
- Genetic testing: useful for cascade screening, not mandatory
- Always exclude secondary causes before labeling
Screening
- Universal pediatric screening (9–11 yrs) is not optional- it’s delayed prevention
- Cascade screening represents the highest yield strategy (and still underused)
Risk
Standard risk calculators?
Useless in FH consequently they underestimate risk
Risk depends on:
- Lifetime LDL exposure
- Lp(a)
- Family history
- Timing of treatment
Treatment (no shortcuts)
Lifelong, early, aggressive
Targets:
- less than 55 mg/dL (secondary prevention)
- less than 70 mg/dL (primary prevention)
Start with:
- High-intensity statin, ezetimibe, PCSK9i / others as needed
- More than or equal to 50% LDL reduction is the floor, not the goal
Take-home
- FH is not a lipid disorder.
- It’s a time-dependent vascular disease.
- Diagnose early, treat hard, treat forever.”
Title: Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar J. Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel E. Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 8, 2026, 12:21William Aird: Developing Patient-Facing Educational Material for The Blood Project
-
Jun 8, 2026, 12:02Glanzmann Thrombasthenia – A Rare but Important Platelet Disorder – Iranian Comprehensive Hemophilia Care Center
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity